Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
12,214
archived clinical trials in
Women's Studies

Maternal Uterine Artery Doppler Study
A Simple Technique to Modify Maternal Uterine Artery Perfusion.
Status: Enrolling
Updated:  11/21/2016
Phoenix Perinatal Associates
mi
from
Glendale, AZ
Maternal Uterine Artery Doppler Study
A Simple Technique to Modify Maternal Uterine Artery Perfusion.
Status: Enrolling
Updated: 11/21/2016
Phoenix Perinatal Associates
mi
from
Glendale, AZ
Click here to add this to my saved trials
Maternal Uterine Artery Doppler Study
A Simple Technique to Modify Maternal Uterine Artery Perfusion.
Status: Enrolling
Updated:  11/21/2016
Phoenix Perinatal Associates
mi
from
Phoenix, AZ
Maternal Uterine Artery Doppler Study
A Simple Technique to Modify Maternal Uterine Artery Perfusion.
Status: Enrolling
Updated: 11/21/2016
Phoenix Perinatal Associates
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS
Status: Enrolling
Updated:  11/22/2016
Penn PCOS Center
mi
from
Philadelphia, PA
Mood and Nutrition Interventions in Polycystic Ovary Syndrome
Improving Psychological Health and Cardiovascular Disease Risk in Women With PCOS
Status: Enrolling
Updated: 11/22/2016
Penn PCOS Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Assessing the CenteringPregnancy Planning to Parent Innovation
Assessing the CenteringPregnancy Planning to Parent Innovation
Status: Enrolling
Updated:  11/22/2016
Boston Med Ctr
mi
from
Boston, MA
Assessing the CenteringPregnancy Planning to Parent Innovation
Assessing the CenteringPregnancy Planning to Parent Innovation
Status: Enrolling
Updated: 11/22/2016
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Kimmel Cancer Center at Thomas Jefferson University - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated:  11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
The Effects of MBSR in Improving Immune Response to Human Papillomavirus in Patients With Cervical Dysplasia
Effects of Mindfulness-Based Stress Reduction (MBSR) on Immune Response to HPV
Status: Enrolling
Updated: 11/29/2016
Fox Chase Cancer Center - Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Supplementation in Adolescent Girls With Endometriosis
SAGE: Supplementation in Adolescent Girls With Endometriosis
Status: Enrolling
Updated:  11/30/2016
Boston Children's Hospital
mi
from
Boston, MA
Supplementation in Adolescent Girls With Endometriosis
SAGE: Supplementation in Adolescent Girls With Endometriosis
Status: Enrolling
Updated: 11/30/2016
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
A Pilot Randomized Control Trial of Advanced Supply of Levonorgestrel Emergency Contraception vs. Routine Postpartum Contraceptive Care in the Teenage Population
Status: Enrolling
Updated:  12/1/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Advance Supply of Emergency Contraception Compared to Routine Postpartum Care in Teens
A Pilot Randomized Control Trial of Advanced Supply of Levonorgestrel Emergency Contraception vs. Routine Postpartum Contraceptive Care in the Teenage Population
Status: Enrolling
Updated: 12/1/2016
Hospital of the University of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated:  12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Pillars4Life Trial
Pillars4Life Randomized Control Trial
Status: Enrolling
Updated: 12/6/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Cranial Cup Use for Correction of Head Shape Deformities
Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants
Status: Enrolling
Updated:  12/8/2016
Boston Children's Hospital
mi
from
Boston, MA
Cranial Cup Use for Correction of Head Shape Deformities
Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants
Status: Enrolling
Updated: 12/8/2016
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Cranial Cup Use for Correction of Head Shape Deformities
Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants
Status: Enrolling
Updated:  12/8/2016
Winchester Hospital
mi
from
Winchester, MA
Cranial Cup Use for Correction of Head Shape Deformities
Cranial Cup Use for the Correction of Positional Head Shape Deformities in Hospitalized Premature Infants
Status: Enrolling
Updated: 12/8/2016
Winchester Hospital
mi
from
Winchester, MA
Click here to add this to my saved trials
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
Status: Enrolling
Updated:  12/13/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
Effect of Weight and Insulin Sensitivity on Reproductive Function in PCOS
Status: Enrolling
Updated: 12/13/2016
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated:  12/13/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated: 12/13/2016
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated:  12/13/2016
University of Alberta
mi
from
Edmonton,
Prader-Willi Syndrome Macronutrient Study
Evidence-Based Approach to Dietary Management of Prader-Willi Syndrome (PWS)
Status: Enrolling
Updated: 12/13/2016
University of Alberta
mi
from
Edmonton,
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of California-Davis
mi
from
Sacramento, CA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of California-Davis
mi
from
Sacramento, CA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
UCSD/Rady Childrens Hospital
mi
from
San Diego, CA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital Colorado
mi
from
Aurora, CO
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of Florida
mi
from
Gainesville, FL
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Kansas University Medical Center
mi
from
Kansas City, KA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Kansas University Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
National Institute of Child Health
mi
from
Bethesda, MD
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
National Institute of Child Health
mi
from
Bethesda, MD
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital and Clinics of Minnesota
mi
from
St. Paul, MN
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital and Clinics of Minnesota
mi
from
St. Paul, MN
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Saint Louis University
mi
from
St. Louis, MO
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Saint Louis University
mi
from
St. Louis, MO
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Winthrop University
mi
from
Mineola, NY
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Winthrop University
mi
from
Mineola, NY
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Vanderbilt University
mi
from
Nashville, TN
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Vanderbilt University
mi
from
Nashville, TN
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Texas Children's Hospital
mi
from
Houston, TX
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University of Utah
mi
from
Salt Lake City, UT
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Seattle Children'S Research Institute
mi
from
Seattle, WA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Seattle Children'S Research Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
Children's Hospital Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated:  12/14/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Beloranib) in Obese Subjects With Prader-Willi Syndrome
Randomized, Double-Blind, Placebo Controlled, Phase 3 Trial of ZGN-440 (Subcutaneous Beloranib in Suspension) in Obese Subjects With Prader-Willi Syndrome to Evaluate Total Body Weight, Food-related Behavior, and Safety Over 6 Months
Status: Enrolling
Updated: 12/14/2016
University Hospitals at Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated:  12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Docetaxel and Radiation Therapy in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer
A Phase I/II Study of Docetaxel as a Radiosensitizer for Locally Advanced Cervical Cancer (GIA 13026)
Status: Enrolling
Updated: 12/14/2016
University of Miami, Sylvester Comprehensive Cancer Center
mi
from
Miami, FL
Click here to add this to my saved trials
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated:  12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder
Measurement of GABA and Neurosteroid Levels in Women With Menopausal Major Depression Before and After Treatment With Estrogen Alone, Fluoxetine Alone, or Estrogen and Fluoxetine and Normal Controls Before and After Treatment With Estrogen
Status: Enrolling
Updated: 12/22/2016
Yale University School of Medicine; Yale Program for Women's Reproductive Behavioral Health
mi
from
New Haven, CT
Click here to add this to my saved trials
Social Media Intervention for Postpartum Depression
Social Media Intervention to Teach Parenting for Women With Postpartum Depression
Status: Enrolling
Updated:  1/3/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Social Media Intervention for Postpartum Depression
Social Media Intervention to Teach Parenting for Women With Postpartum Depression
Status: Enrolling
Updated: 1/3/2017
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
Status: Enrolling
Updated:  1/3/2017
Yale University School of Medicine
mi
from
New Haven, CT
Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
A Controlled Trial of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women
Status: Enrolling
Updated: 1/3/2017
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
miRNA Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
Status: Enrolling
Updated:  1/5/2017
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Micro Ribonucleic Acid (miRNA) Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
miRNA Markers of Hydrocephalus in Intraventricular Hemorrhage (IVH)
Status: Enrolling
Updated: 1/5/2017
St. Joseph's Hospital and Medical Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated:  1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Internet-based System for Cancer Patients to Self-report Toxicity
Pilot Study of STAR, an Internet-based System for Cancer Patients to Self-report Toxicity Symptoms, Performance Status, and Quality of Life
Status: Enrolling
Updated: 1/9/2017
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Following Lipectomy to Understand Adipose Tissue Re-accumulation
Regional Fat Re-accumulation Following Lipectomy in Pre- and Post-menopausal Women
Status: Enrolling
Updated:  1/10/2017
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Following Lipectomy to Understand Adipose Tissue Re-accumulation
Regional Fat Re-accumulation Following Lipectomy in Pre- and Post-menopausal Women
Status: Enrolling
Updated: 1/10/2017
University of Colorado Anschutz Medical Campus
mi
from
Aurora, CO
Click here to add this to my saved trials
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
Implementation of the National Partnership for Maternal Safety Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
Status: Enrolling
Updated:  1/10/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Implementation of the NPMS Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
Implementation of the National Partnership for Maternal Safety Obstetric Hemorrhage Bundle at a Tertiary Center: Utilization of the Delphi Method
Status: Enrolling
Updated: 1/10/2017
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated:  1/12/2017
Baylor College of Medicine
mi
from
Houston, TX
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated:  1/12/2017
Institute of Maternal and Child Health Medicine
mi
from
Kerala,
Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial
Labetalol Versus MgSO4 for the Prevention of Eclampsia Trial (LAMPET)
Status: Enrolling
Updated: 1/12/2017
Institute of Maternal and Child Health Medicine
mi
from
Kerala,
Click here to add this to my saved trials
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
Status: Enrolling
Updated:  1/12/2017
St. Mary's Health Center
mi
from
St. Louis, MO
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
Female Sexual Dysfunction, Risks and Outcomes (FSFI)
Status: Enrolling
Updated: 1/12/2017
St. Mary's Health Center
mi
from
St. Louis, MO
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Birmingham, AL
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Cullman, AL
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Cullman, AL
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Mobile, AL
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Jonesboro, AR
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Jonesboro, AR
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Little Rock, AR
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Little Rock, AR
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Chino, CA
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Chino, CA
Click here to add this to my saved trials
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated:  1/17/2017
Clinical Research Facility
mi
from
Long Beach, CA
A Global Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Elagolix in Subjects With Moderate to Severe Endometriosis-Associated Pain
Status: Enrolling
Updated: 1/17/2017
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials